How to Get NAD+: A Clinic Chair or a 100 mg/mL Vial

Friction here means everything that has to happen before anything is in your hands: gatekeepers, waiting, forms, and money committed in advance of knowing what you are getting.

The ordering is stable, but note that friction and oversight run together. The route that asks the most of you is the route with a licensed professional in it, and the route that asks nothing has nobody in it at all. That is a trade rather than a ranking, and the rest of this page is about what sits on each side of it.

This is the route most people mean by how to get nad iv. Wellness clinics, med spas and mobile infusion services administer NAD+ openly and advertise it for fatigue, focus, recovery and ageing. Those are marketing claims rather than approved indications, and reporting that clinics make them is not the same as adopting them.

What the route asks of you, in order: find a provider, book, complete an intake questionnaire, attend, and sit. A gram-scale infusion is not a brief appointment, which is why chair time is a real component of what is being sold. Payment is usually per session, frequently with a package of several sessions offered at a discount to the single-session rate, and sometimes a membership on top.

What you leave with is an experience, not an object. There is no vial, no lot number and no certificate, and that is the structural difference from every other route. Two questions are worth asking before you commit, and a well-run clinic will not mind either. First, how many milligrams are in the bag, because without that figure nothing they quoted you can be compared to anything. Second, who compounded the preparation and from what grade of bulk substance. Our NAD+ near me page goes further into the local search and NAD+ price handles the cross-channel cost comparison.

This route runs through a prescriber. A consultation happens, in person or by telehealth, the clinician forms a judgement, and if a prescription is written a compounding pharmacy prepares a patient-specific preparation. It is the most supervised route available and the only one where a licensed professional is accountable for what you receive.

Be clear about what that does and does not guarantee. A prescription authorises a preparation. It does not test the powder the preparation was made from, and it does not oblige anybody to tell you where that powder came from.

The regulatory position sits here and is routinely misreported. Nicotinamide Adenine Dinucleotide (NAD) appears in Category 1 of FDA's list of bulk drug substances nominated for use in compounding under section 503A, in the version updated 14 May 2026, alongside the reduced disodium form NADH. Category 1 means FDA does not intend to take action against a compounder for compounding drugs using that substance, provided the conditions described in its guidance are met, while the agency continues to evaluate it. That is non-enforcement pending evaluation. It is not approval, and the list is explicitly provisional. Separately, a Beta-Nicotinamide Adenine Dinucleotide entry sits in Category 3, nominated without adequate support, which is a different position under a name that looks like the same substance. Our NAD+ without prescription page sets all of this out at length.

The honest summary of this route: it exists, it is legitimate, it depends entirely on a clinician agreeing, and it is slower and more expensive than the alternative because a professional's time is inside the price.

Research-chemical suppliers sell lyophilised NAD+ by the gram, labelled for laboratory use and not for human consumption, with no gatekeeper. Ascension Peptides lists a single NAD+ product at 1,000 mg, $104.00 at list and $52.00 with the code PEPTIDEDECK, dispatching the same business day on orders placed before 2pm CST, Monday to Saturday, with free carriage over $250.

What you get is a sealed vial and a published certificate. MZ Biolabs reports lot 25-01260229, analysed 26 January 2026 by HPLC-UV-MS, purity 99.66%, identity confirmed by mass spectrometry, measured quantity 784.32 mg per vial. Kovera Labs covers batch 25-05260628, dated 14 June 2026. The vendor's own FAQ states it cannot discuss reconstitution or dosage, and that lyophilised material should be kept at minus 20 degrees Celsius dry and dark, with reconstituted solution at 4 degrees and used within 28 days.

What you do not get is anybody who is accountable for the material once it arrives. The absence of friction is the absence of a gatekeeper, and those are the same fact described twice. This route also carries the whole burden of the next section.

Every route above ultimately draws on bulk powder that somebody manufactured and somebody else sold on. The question that follows the powder through all three is its grade, and it is invisible from the outside of each of them.

FDA put the problem on record in a compounding notice whose content is current as of 30 October 2024. The agency said it was aware of compounders using food-grade nicotinamide adenine dinucleotide sold by repackagers to make intravenous products, and that ingredients identified as food grade are not suitable for compounding sterile drugs without appropriate processing, because of the high risk of contamination with microbes and endotoxins. It reported adverse event reports following use of NAD+ injectable drugs, including severe chills, shaking, vomiting and fatigue, some requiring medical treatment, in a pattern consistent with excessive levels of endotoxins. It had raised the same concern earlier about the dietary ingredient glutathione.

Two consequences follow. The first is that the highest-friction route is not automatically the safest one, because the failure FDA described happened inside it. The second is that purity is not the relevant number. Endotoxins are bacterial membrane fragments that survive the conditions killing the organism that shed them, which is why a clean chromatogram and a sterile filter can both be true of pyrogenic material, and why the bacterial endotoxins test is a separate assay from purity and identity.

So the question is the same whichever route you take: is the material pharmaceutical grade or food grade, and does an endotoxin result exist for the lot. A clinic can be asked. A pharmacy can be asked. A research supplier can be asked, and note that the two NAD+ certificates published on the listing above report purity, identity and quantity but not a bacterial endotoxins figure. That absence is the ordinary state of this channel, and it is worth knowing rather than assuming.

Most readers of this site land on the third route, so here is what waits there. Laboratory handling arithmetic only; anything about how much material is appropriate belongs on the NAD+ dosage page.

Two cautions on that table. Check the vial's physical capacity before assuming 10 mL of diluent will fit, since headspace is a genuine constraint at gram scale and is the reason gram quantities are often handled at higher concentration. And the assayed row exists because the quantitative certificate reports UV-detectable NAD+, with the laboratory noting that solubility salts and buffering sugars are not normally detected by UV and are not counted as impurities.

The NAD+ calculator will run any volume you enter, our syringe measurement guide covers reading a barrel, and storage covers the cold end of it.